Markets

Orchid Pharma settles ₹2,000 penalty with NSE and BSE for late annual filing

Originally reported by scanx.trade as: Orchid Pharma pays ₹2,000 fine to NSE and BSE for annual report delay

16 Nov 2026, 8:26 pm IST · Xecute.finance News DeskArchive edition

The crisp read

Orchid Pharma has paid a monetary penalty of ₹2,000 to both the National Stock Exchange and Bombay Stock Exchange. The payment was issued due to a delay in submitting the company's annual report.

Xecute Impact Breakdown

For CAs

  • Orchid Pharma paid a financial penalty of ₹2,000 to the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE) for a delay in submitting its annual report.
  • Compliance officers and corporate finance teams must closely monitor annual filing calendars to avoid regulatory penalties and exchange notices.
  • Professionals should maintain robust internal tracking for all stock exchange disclosures and statutory deadlines to protect their client or employer reputation.

For businesses

  • Orchid Pharma incurred a penalty amounting to ₹2,000 paid to the NSE and BSE due to a delay in the submission of its annual report.
  • Listed companies face nominal fines for minor compliance delays compared to severe penalties for prolonged defaults, shifting the burden from previous delayed positions to immediate fee settlements.

Deep dive – the full story

Orchid Pharma has paid a financial penalty amounting to ₹2,000 to the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). The penalty was levied specifically due to a delay in the submission of the company's annual report to the stock exchanges. This regulatory action highlights the strict adherence required by listed entities regarding statutory reporting timelines. Stock exchanges enforce penalties for delayed filings to maintain transparency and protect investor interests in public markets.

Timely disclosure of annual reports ensures that shareholders and analysts have access to audited financial statements within the mandated windows. In practice, listed companies face nominal fines for minor compliance delays compared to severe penalties for prolonged defaults, shifting the burden from previous delayed positions to immediate fee settlements. Compliance officers and corporate finance teams must closely monitor annual filing calendars to avoid regulatory penalties and exchange notices.

Professionals should maintain robust internal tracking for all stock exchange disclosures and statutory deadlines to protect their client or employer reputation. Ultimately, prompt payment of such exchange levies closes the compliance default and keeps the corporate entity in good standing with market regulators.

Source: news.google.com

This is news/educational content, not investment advice. Xecute.finance is not SEBI-registered. Consult a qualified professional before acting.

More from the Xecute news desk

Reading the archive edition.

This story has retired from the live feed - the full text stays here permanently. The live app adds the newest desk, Ask Xecute, deadline trackers and the daily quiz.

Open this story in the Xecute app →